Mitochondrial Transplantation: A Unique Treatment Strategy

Area of Science:

• Regenerative Medicine
• Mitochondrial Biology
• Cardiovascular Research

Background:

• Mitochondrial dysfunction is implicated in various diseases, including ischemia-reperfusion injury.
• Mitochondrial transplantation (MT) has emerged as a novel therapeutic strategy to address cellular damage.
• The technique involves introducing isolated mitochondria into damaged tissues to restore function.

Purpose of the Study:

• To review the evolution and current state of mitochondrial transplantation (MT) research.
• To outline various methods for delivering mitochondria to target sites.
• To discuss the applications of MT in different diseases and ongoing clinical trials.

Main Methods:

• Literature review of studies on MT across different time points.
• Analysis of diverse mitochondrial delivery methods.
• Examination of MT applications in various disease models.
• Synopsis of ongoing human MT clinical studies.

Main Results:

• MT therapy has progressed to the clinical trial stage, especially for heart protection against ischemia-reperfusion injury.
• Research has focused on replacing damaged mitochondria or enhancing intercellular mitochondrial transfer.
• Various delivery techniques have been developed to introduce mitochondria into target organs.

Conclusions:

• Mitochondrial transplantation holds significant potential for treating mitochondrial defect-related diseases.
• Further research is needed to overcome existing challenges in human MT.
• MT offers new therapeutic avenues for regenerative medicine and organ protection.